EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 51 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,787,500 | +39.1% | 375,000 | +36.4% | 0.05% | +34.2% |
| Q3 2022 | $2,723,000 | +1.2% | 275,000 | 0.0% | 0.04% | -7.3% |
| Q2 2022 | $2,692,000 | +0.5% | 275,000 | 0.0% | 0.04% | -4.7% |
| Q1 2022 | $2,679,000 | +0.5% | 275,000 | 0.0% | 0.04% | +13.2% |
| Q4 2021 | $2,665,000 | -0.1% | 275,000 | 0.0% | 0.04% | -13.6% |
| Q3 2021 | $2,668,000 | +0.5% | 275,000 | 0.0% | 0.04% | -10.2% |
| Q2 2021 | $2,654,000 | – | 275,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |